Anticardiolipin (aCL) antibodies in a patient with Behçet's syndrome with vena cava inferior thrombosis.
This case report describes a patient with Behçet's syndrome with sustained anticardiolipin antibodies presenting a vena cava inferior thrombosis in a period of anabolic steroid use. The vascular manifestations and occurrence of antiphospholipid antibodies in Behçet's syndrome are reviewed. The possible thrombogenicity of anabolic steroids is reemphasized.
Ebo
D G
DG
Department of Immunology-Allergology-Rheumatology, University of Antwerp.
Bracke
P G
PG
De Clerck
L S
LS
Francx
L M
LM
Stevens
W J
WJ
D045930:Anabolic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D017153:Antibodies, Anticardiolipin / Q000032:analysis / Q000097:blood*; D001528:Behcet Syndrome / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D002544:Cerebral Infarction / Q000150:complications* / Q000000981:diagnostic imaging / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D013197:Stanozolol / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D013927:Thrombosis / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000276:immunology; D018608:Ultrasonography, Doppler; D014682:Vena Cava, Inferior
D045930:Anabolic Agents; D017153:Antibodies, Anticardiolipin; D013197:Stanozolol